NORBERTO
ORTEGO CENTENO

CATEDRÁTICO DE UNIVERSIDAD

Foto de NORBERTO

Foto de Hospital de Fuenlabrada

Hospital de Fuenlabrada

Fuenlabrada, España

Publicaciones en colaboración con investigadores/as de Hospital de Fuenlabrada (6)

2024

Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis
Autoimmunity Reviews

2021

Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))
Autoimmunity Reviews
Immune thrombocytopenia and COVID-19: Case report and review of literature
Lupus, Vol. 30, Núm. 9, pp. 1515-1521

2020

Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Autoimmunity Reviews, Vol. 19, Núm. 5

2016

Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399

2011

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
Arthritis Research and Therapy, Vol. 13, Núm. 4